~~<i id='B619EF7120'><strike id='B619EF7120'><tt id='B619EF7120'><pre id='B619EF7120'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：Wikipedia 2025-10-02 20:52:39 - browse：8544

Stoke Therapeutics is still seeking an effective dose for an experimental drug to treat a severe form of childhood epilepsy, following the release of updated data Tuesday that showed disappointing reductions in convulsive seizure activity.

In the latest look at an ongoing mid-stage study, three monthly injections of the Stoke drug, called STK-001, given at a 45-mg dose, resulted in a median 18% reduction in convulsive seizure activity, compared to baseline.

The new analysis was conducted on 16 children diagnosed with a rare form of epilepsy called Dravet syndrome. Last November, in six patients, the drug showed a median 55% reduction in seizure activity.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Neuroscience startup Neumora files for IPO

leisure time

knowledge

leisure time

explore

entertainment

AdobeAcommonlyusedtreatmentforpeoplewithkneeosteoarthritisisbarelymoreeffectivethantheplaceboeffecti

WSS

HIPAA doesn't protect reproductive records from prosecutors

A double vaccine crisis is endangering millions of children

Medicare explains how it will choose drugs for negotiation

How Long Island became the ‘eugenics capital of the world’

Australia’s approach to dialysis celebrates life

HIPAA doesn't protect reproductive records from prosecutors

focus

comprehensive

leisure time

Jerome Adams on the need for new antivirals for Covid

What do new weight loss drugs mean for bariatric surgery?

As demand for Covid shots wanes, Moderna seeks its next success

A double vaccine crisis is endangering millions of children

Activists slam private health insurers over coverage restrictions

FDA official pushes for dedicated emerging pathogens team

Activists slam private health insurers over coverage restrictions

CDC backtracks, saying fully vaccinated people can go maskless indoors

New air purifier tech could be key to improving indoor air quality

Australia’s approach to dialysis celebrates life

leisure time

Organ transplantation is at a crossroads. Major reform is needed

Body of missing toddler recovered in Delaware River days after flood: Police

7 of the most gruesome medical devices in history

How to make Best Hospitals ratings actually useful for patients

As pharma fights Medicare drug negotiation, hospitals, docs silent

Radiation, mainstay of cancer treatment, begins a fade

knowledge

leisure time

explore

entertainment